Arkolith/Insider Trading/SGMO/Form 4

Dubois-Stringfellow Nathalie

SVP-CHIEF DEVELOPMENT OFFICERSANGAMO THERAPEUTICS, INC (SGMO) · full profile →Form 4 · filed Feb 26, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 25, 2025Tax withholding(F)2K$0.96$1K713K
Feb 25, 2025Grant(A)120K—$0833K
Feb 24, 2025Tax withholding(F)2K$1.00$2K715K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 25, 2025Grant(A)560K—$0560K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-005707) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML